vTv Therapeutics (VTVT) Receivables (2015 - 2024)
vTv Therapeutics (VTVT) reported Receivables of $62000.0 for Q4 2024, down 39.22% on a YoY basis from $102000.0 in Q1 2024, and down 74.38% sequentially from $242000.0 in Q3 2024.
vTv Therapeutics (VTVT) Receivables (2015 - 2024) Analysis & Trends
vTv Therapeutics (VTVT) has 10 years of Receivables data on file, last reported at $62000.0 in Q4 2024.
- For the quarter ending Q4 2024, Receivables fell 39.22% year-over-year to $62000.0; the trailing twelve-month figure through Dec 2024 stood at $62000.0 (down 39.22% YoY), and the FY2024 full-year result was $62000.0, down 39.22% from the prior year.
- Receivables declined to $62000.0 in Q4 2024, from $242000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $12.5 million in Q2 2022 to a low of $2000.0 in Q1 2021.
- A 5-year average of $3.1 million and a median of $173000.0 in 2022 frame the typical range for Receivables.
- Across the five-year window, Receivables soared 21829.82% in 2023 and tumbled 97.55% in 2024, its largest moves.
- Tracing VTVT's Receivables over 5 years: stood at $158000.0 in 2020, then plunged by 63.92% to $57000.0 in 2021, then jumped by 203.51% to $173000.0 in 2022, then sank by 41.04% to $102000.0 in 2023, then slumped by 39.22% to $62000.0 in 2024.
- Business Quant data shows VTVT's Receivables at $62000.0 in Q4 2024, $242000.0 in Q3 2024, and $306000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 242,000.00 |
| Jun 30, 2024 | 306,000.00 |
| Mar 31, 2024 | 981,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Jun 30, 2023 | 12.50 Mn |
| Mar 31, 2023 | 12.50 Mn |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 12.50 Mn |
| Jun 30, 2022 | 12.50 Mn |
| Mar 31, 2022 | 57,000.00 |
| Dec 31, 2021 | 57,000.00 |
| Sep 30, 2021 | 928,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 158,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Mar 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Sep 30, 2019 | 10,000.00 |
| Jun 30, 2019 | 1.82 Mn |